Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Orphan drug designation awarded to Neovastat in renal cell carcinoma

Nov. 4, 2002

Genasense in combination with Rituxan evaluated in NHL patients

Nov. 4, 2002

Advexin studied in combination with docetaxel and doxorubicin for advanced breast cancer

Oct. 31, 2002

New data on the tolerability of BBR-3438 in advanced solid tumors

Oct. 31, 2002

Improved safety profile reported for liposome-encapsulated mitoxantrone in advanced cancer

Oct. 31, 2002

R-115777 in myelodysplastic syndrome

Oct. 31, 2002

Potential use of MEN-10755 in recurrent non-small cell lung cancer

Oct. 31, 2002

CDK1 inhibitors in early development at Aventis

Oct. 31, 2002

Aventis presents novel telomerase-inhibitory antitumor agents

Oct. 31, 2002

New modulators of nuclear hormone receptors covered by BMS patent

Oct. 31, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...